Avalo Therapeutics (AVTX) 2025 Conference Transcript

Avalo Therapeutics (AVTX) 2025 Conference May 08, 2025 03:00 PM ET Speaker0 At the the Citizens Life Science Conference. Excited to be joined next by, Avalo Therapeutics. Avalo is a company focused on, targeting an immune mediated disease. The the lead program is in Hydrodentis Supertiva and phase two trials ongoing now and data expected next year. Welcome Gary McNeil, the CEO. Appreciate you being here and looking forward to the presentation. Speaker1 Thank you, yeah, it's really exciting to be here. Even ...